Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

L.A. McKeown

April 18, 2024

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

Todd Neale

December 06, 2023

News Daily News

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

L.A. McKeown

September 20, 2023

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

News Daily News

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

Todd Neale

November 01, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Daily News

Skin Cancer Risk With Common Diuretics Confirmed Anew

L.A. McKeown

April 14, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

Advertisement

FDA Approves Aficamten for Obstructive HCM

December 2025 Dispatch for the CV Team

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Skin Cancer Risk With Common Diuretics Confirmed Anew

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content